Analysis of the loss of heterozygosity (LOH) detected by polymerase chain reaction techniques using 18 polymorphic markers localized to chromosomes 3p, 5, 17, and 18q in 40 Hong Kong. Chinese esophageal squamous cell carcinoma (ESC) patients showed that multiple alterations on several chromosomes are involved in ESC development. The LOH rates detected for markers on chromosome 3 ranged from 44.0 to 85.7\%, for chromosome 5 from 40.9 to 61.9\%, for chromosome 17 from 40.0 to 100\%, and for chromosome 18 from 38.9 to 58.3\%. No significant association was observed between LOH and the clinical and histopathological parameters. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved
The incidence/mortality rates of esophageal squamous cell carcinoma (ESCC) vary widely in different ...
Esophageal cancers have a unique geographical distribution yet contribute to cancer mortality worldw...
AIM: To study the loss of heterozygosity (LOH) on 12p12-13 in Chinese colon carcinoma patients. METH...
Analysis of the loss of heterozygosity (LOH) detected by polymerase chain reaction techniques using ...
Multiple and extensive alterations in chromosome 9 were detected in thirty-four esophageal squamous ...
Multiple and extensive alterations in chromosome 9 were detected in thirty-four esophageal squamous ...
Esophageal squamous cell carcinoma (ESCC) is a major cause of cancer death in China, but its etiolog...
In order to characterize the molecular events in the carcinogenesis of esophageal cancer and to iden...
In order to identify representative genetic alterations in esophageal squamous cell carcinomas (ESCC...
Esophageal cancer (ESC) is an important cancer worldwide. Chromosome 11 plays an important role in t...
Loss of heterozygosity (LOH) and microsatellite instability (MSI) have been recognized as important ...
OBJECTIVE: To characterize the profile of chromosomal imbalances of esophageal squamous cell carcino...
Sixty primary esophageal squamous cell carcinomas (ESCCs) were evaluated for cytogenetic changes by ...
Sixty primary esophageal squamous cell carcinomas (ESCCs) were evaluated for cytogenetic changes by ...
Sixty primary esophageal squamous cell carcinomas (ESCCs) were evaluated for cytogenetic changes by ...
The incidence/mortality rates of esophageal squamous cell carcinoma (ESCC) vary widely in different ...
Esophageal cancers have a unique geographical distribution yet contribute to cancer mortality worldw...
AIM: To study the loss of heterozygosity (LOH) on 12p12-13 in Chinese colon carcinoma patients. METH...
Analysis of the loss of heterozygosity (LOH) detected by polymerase chain reaction techniques using ...
Multiple and extensive alterations in chromosome 9 were detected in thirty-four esophageal squamous ...
Multiple and extensive alterations in chromosome 9 were detected in thirty-four esophageal squamous ...
Esophageal squamous cell carcinoma (ESCC) is a major cause of cancer death in China, but its etiolog...
In order to characterize the molecular events in the carcinogenesis of esophageal cancer and to iden...
In order to identify representative genetic alterations in esophageal squamous cell carcinomas (ESCC...
Esophageal cancer (ESC) is an important cancer worldwide. Chromosome 11 plays an important role in t...
Loss of heterozygosity (LOH) and microsatellite instability (MSI) have been recognized as important ...
OBJECTIVE: To characterize the profile of chromosomal imbalances of esophageal squamous cell carcino...
Sixty primary esophageal squamous cell carcinomas (ESCCs) were evaluated for cytogenetic changes by ...
Sixty primary esophageal squamous cell carcinomas (ESCCs) were evaluated for cytogenetic changes by ...
Sixty primary esophageal squamous cell carcinomas (ESCCs) were evaluated for cytogenetic changes by ...
The incidence/mortality rates of esophageal squamous cell carcinoma (ESCC) vary widely in different ...
Esophageal cancers have a unique geographical distribution yet contribute to cancer mortality worldw...
AIM: To study the loss of heterozygosity (LOH) on 12p12-13 in Chinese colon carcinoma patients. METH...